Rezolute
Gil Labrucherie is the current director at Rezolute. Prior to this role, they served as the Chief Operating Officer and Chief Financial Officer at Nektar Therapeutics from 2016 to 2022. Gil was also the General Counsel & Senior Vice President at Nektar Therapeutics from 2005 to 2016. Prior to that, they were the Vice President of Corporate Development at E2open from 2000 to 2005 and the Director of Corporate Development at AltaVista Company from 1999 to 2000.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Rezolute
Rezolute is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases.